Amol Akhade/LinkedIn
Mar 11, 2025, 08:46
Amol Akhade: Matterhorn Trial positive for EFS
Amol Akhade, Senior Consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:
“Matterhorn Trial positive for EFS. Press release.
It will be interesting to see how PCR Co-related with EFS Delta of EFS and added toxicity.
FLOT Plus Durvalumab can be potentially new SOC.
Looking forward to the data.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26